Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia
Clinical trial NCT04362813 · COMPLETED
Trial details
- NCT number
- NCT04362813
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-30
- Primary completion
- 2020-09-16
- Enrollment
- 454
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.